This topic contains a solution. Click here to go to the answer

Author Question: Of the five characteristics of damaged brain processes associated with dementia, the one involving ... (Read 6 times)

shenderson6

  • Hero Member
  • *****
  • Posts: 573
Of the five characteristics of damaged brain processes associated with dementia, the one involving gradual deterioration of different brain areas is
 
  a. atrophy.
  b. degradation.
  c. cellular reduction.
  d. synapse pruning.

Question 2

A policy about including women and members of minority groups in studies of human participants has been established by the
 
  a. NIH.
  b. APA.
  c. AMA.
  d. none of these have policies regarding women and members of minority groups.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

skipfourms123

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

a

Answer to Question 2

a




shenderson6

  • Member
  • Posts: 573
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


apple

  • Member
  • Posts: 352
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library